The Support. Don't Punish Global Day of Action reflects the growing movement against the 'war on drugs', uniting communities under a shared banner to demand rights-affirming drug policies, harm reduction, and collective action for a fairer future.
Nelson and Klantschnignd shine a light on farmers' relationship with legally regulated markets, including critical responses to models that neglect their inclusion.
Ahead of the UN CESCR's 77th Session, IDPC supports three bold submissions in Kenya and the UK, assessing their drug policies and human rights records, and demanding urgent reform.
SWAN examines the social justice impact of intersecting identities and provides recommendations for improving services, rights-based programs, and advocacy.
IDPC's assessment of the World Drug Report's chapter on the right to health suggests that UNODC prioritises its own policy interests over reflecting the negative impacts of the 'war on drugs' and the most recent guidance on the matter.
The UNAIDS Programme Coordinating Board report qualitatively outlines obstacles to realising global targets for community-led HIV/AIDS service delivery, calling for equitable financing and resilience against anti-rights movements.
Youth RISE advocates for an intersectional approach to harm reduction that considers both the immediate and underlying structural factors contributing to harm.
WHRIN catalogues gender-responsive harm reduction services around the world, highlighting a stark disparity between need and availability driven by criminalisation and stigma.
DPA and HRI condemn the US' multibillion-dollar contribution to punitive responses, urging greater transparency and a commitment to a rights-based approach.
IDPC was delighted to join the launch of the Charter, welcoming its commitment to civil society engagement and encouraging political leadership to resource its implementation.
The Global Commission on Drug Policy exposes prohibitionist policies' role in fueling inequities and offers a roadmap for reform including harm reduction measures, decriminalsiation, and the legal regulation of drug markets,
